Last updated: January 11, 2026
Sponsor: HaEmek Medical Center, Israel
Overall Status: Completed
Phase
N/A
Condition
N/ATreatment
Clindamycin
Metronidazole
Clinical Study ID
NCT01722708
0012-12-EMC
Ages 18-50 Female Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Pregnant women at increased risk for preterm labor (preterm cervical effacement,preterm uterine contractions, twins pregnancy, vaginal bleeding, past pretermdelivery)
Age above 18 years
Exclusion
Exclusion Criteria:
Known allergy to the tested antibiotics
Antibacterial treatment in the week before the vaginal culture was taken
preterm premature rupture of membranes
Study Design
Total Participants: 166
Treatment Group(s): 2
Primary Treatment: Clindamycin
Phase:
Study Start date:
November 01, 2012
Estimated Completion Date:
December 30, 2025
Connect with a study center
Departement of obstetric and gynecology, Poriya Medical Center
Tiberias 293322, Israel
IsraelSite Not Available
Departement of obstetric and gynecology, HaEmek medical center
Afula,
IsraelSite Not Available
Departement of obstetric and gynecology, HaEmek medical center
Afula 295740,
IsraelSite Not Available
Departement of obstetric and gynecology, Poriya Medical Center
Tiberias,
IsraelSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.